tiprankstipranks
Trending News
More News >
Neurosense Therapeutics Ltd. (NRSN)
NASDAQ:NRSN
US Market

Neurosense Therapeutics Ltd. (NRSN) Cash flow

Compare
178 Followers

Neurosense Therapeutics Ltd. Cash Flow

NRSN's free cash flow for Q2 2025 was $-2.00K. For the 2025 fiscal year, NRSN's free cash flow was decreased by $-1.75M and operating cash flow was $-2.00K. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -10.13M$ -8.35M$ -7.59M$ -1.54M$ -695.00K
Investing Cash Flow
$ 1.00K$ 3.47M$ -3.54M$ -17.00K$ -9.00K
Financing Cash Flow
$ 10.91M$ 3.98M$ 3.69M$ 11.90M$ 508.00K
End Cash Position
$ 3.38M$ 2.64M$ 3.54M$ 11.06M$ 699.00K
Free Cash Flow
$ -10.14M$ -8.38M$ -7.66M$ -1.56M$ -704.00K
Currency in USD

Neurosense Therapeutics Ltd. Cash Flow